Search results
There is a page named "Ifinatamab deruxtecan" on Wikipedia
Ifinatamab deruxtecan (DS-7300) is an experimental anti-cancer treatment developed by Merck and Daiichi Sankyo. It is an antibody–drug conjugate that...4 KB (211 words) - 14:28, 7 April 2024
lung cancer. Ifinatamab deruxtecan, an experimental anti-cancer treatment. "A HER2-Targeting Antibody–Drug Conjugate, Trastuzumab Deruxtecan (DS-8201a)...10 KB (586 words) - 14:33, 26 March 2024
pipeline include: Datopotamab deruxtecan (Dato-DXd) Patritumab deruxtecan (HER3-DXd) VN-0102 DS-1647 Ifinatamab deruxtecan (I-DXd; DS-7300) "Our Leadership...29 KB (2,326 words) - 13:59, 3 May 2024
